Radius Health Provides Business Update on Bone Health
Exclusive extension of research discovery collaboration with Mass General Hospital (MGH)Focus of the program: development of novel oral SIK inhibitors...
News
Panbela Schedules Conference Call on March 24, 2022, to Report 2021 Fourth Quarter Financial Results
MINNEAPOLIS, March 08, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
TOMI Joins Forces with a Premier U.S. Manufacturing Partner ARM EnerTech Associates
FREDERICK, Md., March 08, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes...
Clearmind Medicine, SciSparc Launch a Psychedelic Pharma Collaboration
The companies have begun the Collaboration with a joint pre-clinical study and are expecting its results potentially to deepen the...
BrightInsight and UCB Partner to Build Digital Care Solutions for Rare Diseases
UCB’s Digital Care Solutions for Myasthenia Gravis to be Built on the BrightInsight PlatformSAN JOSE, Calif., March 08, 2022 (GLOBE...
Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th
Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY, March 08, 2022 (GLOBE NEWSWIRE)...
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
BioNTech and Regeneron plan to jointly conduct clinical trials evaluating FixVac candidate BNT116 in combination with Libtayo for the treatment...
Sanofi recognized by S&P as one of the most sustainability-committed companies
Sanofi recognized by S&P as one of the most sustainability-committed companies Paris, March 8, 2022. Sanofi was today recognized as...
Catalyst Pharmaceuticals Named Among Forbes 2022 America’s Best Small Companies
The Company Ranked 65th of More Than 1,000 Companies AssessedCORAL GABLES, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals,...
Amedisys to Present at Multiple Healthcare Conferences in March
BATON ROUGE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Achilles Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference
LONDON, March 08, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell...
Monopar to Present at the 34th Annual Roth Conference and Maxim’s 2022 Virtual Growth Conference
WILMETTE, Ill., March 08, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
GelStat Provides Corporate Update on Capital Restructuring
STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company...
Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
Achieve Life Sciences Announces Participation in March Investor Conferences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage...
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time
RALEIGH, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers...
VBL Therapeutics Announces Completion of Enrollment in OVAL Phase 3 Registration-Enabling Trial of Ofra-Vec in Ovarian Cancer and Unanimous Recommendation by Independent Data Safety Monitoring Committee to Continue Study as Planned
Phase 3 OVAL trial enrolled 409 patients globally at centers in the United States, Europe, Israel, and JapanTop-line data from...
X4 Pharmaceuticals to Announce Fourth Quarter 2021 Financial Results and Host a Conference Call and Webcast on March 17, 2022
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel...
The iQ Group Global secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing
Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitionersSYDNEY, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Antisoma...
Ocuphire Completes Enrollment in MIRA-4 Pediatric Safety Trial Evaluating Nyxol® for Reversal of Mydriasis
With Growing Rate of Childhood Myopia, MIRA-4 Trial Supports a Potential Broader RM Label for Nyxol in Pediatric Subjects 3...
